
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
COG5 CRISPR/Cas9 KO Plasmid (h) | sc-411474 | 20 µg | $397.00 |
COG5 encodes a core subunit of the conserved oligomeric Golgi (COG) tethering complex that coordinates retrograde vesicle trafficking within the Golgi apparatus. By supporting vesicle docking and SNARE-dependent fusion, COG5 helps maintain Golgi architecture, enzyme localization, and efficient processing of secretory cargo. Disruption of COG complex function perturbs glycosylation homeostasis and can alter cell-surface and extracellular matrix composition, affecting pathways linked to protein sorting, secretion, and membrane organization. Variants in COG5 and related COG components have been associated with congenital disorders of glycosylation and broader phenotypes connected to defective Golgi trafficking.
COG5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the COG5 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the COG5 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the COG5 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish COG5 protein expression.
This CRISPR knockout system enables efficient generation of COG5-deficient cell models for investigation of COG5 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.